MEDIQON Group AG (CHG) AI Stock Analysis

• Market Cap: €770.10M
• Dividend Yield: N/A
• Average Volume (3M): 26.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.03
• Revenue Growth: 51.05%
• EPS Growth: -242.58%
• Country: DE
• Employees: 800
• Sector: Technology
• Sector Strength: 88
• Industry: Information Technology Services
• EPS (TTM): -0.69
• Shares Outstanding: 23,842,152
• 10 Day Avg. Volume: 27,625
• 30 Day Avg. Volume: 26,381
• PEG Ratio: -0.40
• Price to Book (P/B): 2.59
• Price to Sales (P/S): 5.28
• P/FCF Ratio: 83.86
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.45
• Revenue Forecast (FY): €237.05M

• Rating: 45 Neutral
• Price Target: €40.00 ▼(-1.48% Downside)
• Action: Reiterated Date: 11/01/25
• Date: Action: Reiterated 11/01/25

The overall stock score for MEDIQON Group AG is primarily influenced by its financial performance, which shows strong revenue growth but significant profitability challenges. Technical analysis indicates a lack of strong momentum, while valuation is negatively impacted by the company's unprofitability and lack of dividend yield. The absence of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

Revenue Growth

Sustained revenue expansion indicates growing market adoption of MEDIQON's devices and software. Durable top-line growth supports scale, improves leverage on fixed costs, and creates optionality for reinvesting in product R&D and commercial expansion over the next several quarters.

Negative Factors

Unprofitability and Negative Margins

Persisting negative net income and EBIT margins show the company is not yet converting sales into profit. This structural profitability shortfall constrains retained earnings, limits reinvestment, and may require ongoing external capital if not remedied within the medium term.

MEDIQON Group AG Business Overview & Revenue Model

Company Description

CHAPTERS Group AG, together with its subsidiaries, provides software solutions in the DACH region. It also provides building cleaning and related services; electronic gate and door systems, as well as barriers, fire, and smoke protection systems; ...

Read more

CHAPTERS Group AG, together with its subsidiaries, provides software solutions in the DACH region. It also provides building cleaning and related services; electronic gate and door systems, as well as barriers, fire, and smoke protection systems; ...

How the Company Makes Money

MEDIQON Group AG generates revenue through multiple streams, primarily from the sale of medical devices and technology solutions to healthcare providers, hospitals, and clinics. The company also earns income from licensing its proprietary software...

Read more

MEDIQON Group AG generates revenue through multiple streams, primarily from the sale of medical devices and technology solutions to healthcare providers, hospitals, and clinics. The company also earns income from licensing its proprietary software...

MEDIQON Group AG Financial Statement Overview

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2021	Dec 2021	Dec 2020
Income Statement
Total Revenue	131.62M	110.67M	70.77M	42.07M	28.66M	1.08M
Gross Profit	-2.22M	47.02M	8.38M	6.84M	12.26M	360.69K
EBITDA	1.59M	16.35M	16.14M	4.82M	7.16M	-1.33M
Net Income	-23.07M	-11.47M	-4.08M	-5.88M	-2.27M	-2.27M
Balance Sheet
Total Assets	591.39M	353.74M	223.95M	169.28M	103.55M	49.81M
Cash, Cash Equivalents and Short-Term Investments	52.20M	58.51M	50.84M	26.28M	11.09M	614.04K
Total Debt	200.34M	73.60M	69.35M	62.09M	51.70M	25.00M
Total Liabilities	306.36M	128.75M	99.87M	77.11M	61.71M	41.55M
Stockholders Equity	224.81M	224.99M	126.06M	93.76M	42.57M	10.00M
Cash Flow
Free Cash Flow	10.70M	6.96M	3.81M	3.67M	1.15M	-1.76M
Operating Cash Flow	13.38M	11.47M	7.37M	5.69M	2.87M	-1.76M
Investing Cash Flow	-147.02M	-98.82M	-36.34M	-53.21M	-47.40M	-5.21M
Financing Cash Flow	135.34M	89.00M	48.15M	58.78M	47.06M	7.22M

MEDIQON Group AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 40.60
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:CHG, the sentiment is Negative. The current price of 40.6 is above the 20-day moving average (MA) of 32.73, above the 50-day MA of 31.42, and above the 200-day MA of 37.48, indicating a neutral trend. The MACD of 0.48 indicates Positive momentum. The RSI at 50.14 is Neutral, neither overbought nor oversold. The STOCH value of 47.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:CHG.

MEDIQON Group AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NA9	68 Neutral	€614.33M	7.63	25.95%	1.29%	5.63%	-7.19%
D6H	62 Neutral	€632.32M	24.56	13.51%	1.43%	7.30%	-15.88%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
GFT	60 Neutral	€483.34M	14.91	12.64%	2.65%	3.28%	-26.16%
COK	59 Neutral	€805.22M	29.11	5.18%	3.78%	-0.61%	-52.28%
ADN1	54 Neutral	€379.29M	13.08	7.22%	0.85%	12.37%	196.11%
CHG	45 Neutral	€770.10M	-15.32	-10.26%	―	51.05%	-242.58%